Hyundai Bioscience Co., Ltd. (048410.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−31.5x

Market Cap

KRW 581.05B

MomentumView details →

1D Return

−0.49%

YTD Return

+25.08%

RSI (14)

40.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−31.5x

Market Cap

KRW 581.05B

RSI (14)

40.5

MomentumView details →

1D Return

−0.49%

YTD Return

+25.08%

ProfitabilityView details →

Gross Margin

−21.22%

Net Margin

−796.63%

EBITDA Margin

−537.29%

ROE (TTM)

−25.62%

ROA (TTM)

−20.15%

Asset Turnover

0.03x

GrowthView details →

Revenue YoY

+77.96%

EPS YoY

−16.55%

FCF YoY

—

Revenue CAGR 3Y

−23.48%

EPS CAGR 3Y

—

EBITDA YoY

−72.67%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.22x

Current Ratio

2.36x

Quick Ratio

2.32x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

3.32B

Net Income (TTM)

−26.45B

Op. CF (TTM)

−16.62B

Latest newsMore news →

No recent news for 048410.KQ.

Similar companies

Komipharm International Co., Ltd.041960.KQ GC Biopharma Corp.006280.KS Mezzion Pharma Co.,Ltd.140410.KQ ST Pharm Co.,Ltd.237690.KQ Sam Chun Dang Pharm. Co., Ltd000250.KQ ABL Bio Inc.298380.KQ Find similar companies →

Latest newsMore news →

No recent news for 048410.KQ.